USD 107.78
(-3.47%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 4.19 Billion | 3.02 Billion | 2.18 Billion | 2.98 Billion | 2.86 Billion | 2.99 Billion |
Net Income | 4.6 Billion | 3.01 Billion | 1.85 Billion | 1.29 Billion | 2.38 Billion | 2.19 Billion |
Depreciation & Amortization | -923.9 Million | 790.2 Million | 903.3 Million | 1.04 Billion | 1.07 Billion | 1.05 Billion |
Deferred income taxes | -303.7 Million | -208 Million | -212.9 Million | -500 Thousand | 70.8 Million | 17.5 Million |
Stock-based compensation | 21.2 Million | 17.1 Million | 14.7 Million | 13 Million | 15.1 Million | 13.2 Million |
Change in working capital | -1.33 Billion | -809.5 Million | -239 Million | 891.2 Million | -595.5 Million | -558.1 Million |
Other non-cash items | 1.84 Billion | 207 Million | -329.7 Million | -251.4 Million | -9.4 Million | 283.7 Million |
Investing Cash Flow | -2.87 Billion | -2.03 Billion | -1.36 Billion | -1.87 Billion | -2.2 Billion | -1.93 Billion |
Investments in PPE | -1.26 Billion | -1.39 Billion | -1.63 Billion | -1.63 Billion | -1.97 Billion | -1.95 Billion |
Acquisitions | 632 Million | 687.7 Million | -727 Million | -597.8 Million | 638.1 Million | 653.7 Million |
Investment purchases | -163.6 Million | -170.3 Million | -176.1 Million | -244.6 Million | -850.6 Million | -615.9 Million |
Sales/Maturities of investments | 803.6 Million | 718.1 Million | 727 Million | 597.8 Million | 715.5 Million | 931.5 Million |
Other Investing Activities | -2.88 Billion | -1.87 Billion | 446.2 Million | 7.2 Million | -739.6 Million | -294 Million |
Financing Cash Flow | 1.1 Billion | 304.9 Million | -882.9 Million | -1.8 Billion | 83.4 Million | 71.1 Million |
Debt repayment | -2.57 Billion | -2.26 Billion | -210.9 Million | -1.89 Billion | -1.79 Billion | -1.75 Billion |
Dividends payments | -1.51 Billion | -1 Billion | -708 Million | -1.23 Billion | -1.13 Billion | -804.3 Million |
Common Stock Repurchased | -3.5 Million | -2.1 Million | -1.5 Million | -42.1 Million | -110.2 Million | -354.4 Million |
Common Stock Issuance | 51.5 Million | 35.7 Million | 37.5 Million | 53.7 Million | 60.8 Million | 19.3 Million |
Other Financing Activities | 5.14 Billion | 3.54 Billion | -882.9 Million | 1.31 Billion | 3.06 Billion | 2.98 Billion |
Accounts receivables | -1.26 Billion | 125.9 Million | -329.8 Million | 20 Million | -75.3 Million | -45.8 Million |
Accounts payables | 350.7 Million | 840.3 Million | 1.03 Billion | -53.6 Million | -27.6 Million | 528.9 Million |
Inventory | -350.7 Million | -272.7 Million | -610.3 Million | -48.2 Million | 24.6 Million | -332.7 Million |
Other working capital | -68.2 Million | -1.5 Billion | -329.8 Million | 973 Million | -517.2 Million | -708.5 Million |
Cash at beginning of period | 4.69 Billion | 3.42 Billion | 3.53 Billion | 4.17 Billion | 3.43 Billion | 2.36 Billion |
Cash at end of period | 2.42 Billion | 4.69 Billion | 3.42 Billion | 3.53 Billion | 4.17 Billion | 3.43 Billion |
Capital Expenditure | -1.26 Billion | -1.39 Billion | -1.63 Billion | -1.63 Billion | -1.97 Billion | -1.95 Billion |
Effect of forex changes on cash | 69.6 Million | -36.3 Million | -52.4 Million | 61.6 Million | 2.9 Million | -61.5 Million |
Net cash flow / Change in cash | -2.26 Billion | 1.26 Billion | -111.3 Million | -635.5 Million | 739.2 Million | 1.07 Billion |
Free Cash Flow | 2.92 Billion | 1.63 Billion | 553.9 Million | 1.34 Billion | 889.5 Million | 1.04 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 972.1 Million | 1.12 Billion | 1.19 Billion | 4.6 Billion | 1.41 Billion | 1.22 Billion |
Depreciation & Amortization | 226.8 Million | 231.9 Million | 235 Million | -923.9 Million | -245.5 Million | -233.9 Million |
Deferred income taxes | - | - | - | -303.7 Million | -303.7 Million | -2.5 Million |
Stock-based compensation | 6.8 Million | 3.1 Million | 35.4 Million | 21.2 Million | 2.8 Million | 2.5 Million |
Change in working capital | 104.3 Million | -920.4 Million | 38.7 Million | -1.33 Billion | -594.2 Million | -115.1 Million |
Other non-cash items | -17 Million | 1.06 Billion | 277.9 Million | 1.84 Billion | 609.1 Million | 463.5 Million |
Investing Cash Flow | -1.18 Billion | -1.04 Billion | -526.1 Million | -2.87 Billion | -939.8 Million | -886.4 Million |
Investments in PPE | -378.1 Million | -512.79 Million | -351.8 Million | -1.26 Billion | -363.4 Million | -335.7 Million |
Acquisitions | 42.6 Million | 183.8 Million | 168.9 Million | 632 Million | 183 Million | 132.1 Million |
Investment purchases | -524.6 Million | -512.2 Million | -25.8 Million | -163.6 Million | 633.1 Million | -236.5 Million |
Sales/Maturities of investments | 220 Million | 200.7 Million | 294.1 Million | 803.6 Million | -3.88 Billion | 169.1 Million |
Other Investing Activities | -502.8 Million | -403.2 Million | -317.4 Million | -2.88 Billion | 2.49 Billion | -615.4 Million |
Financing Cash Flow | 812.9 Million | 300.7 Million | -1.88 Billion | 1.1 Billion | 942.7 Million | 358.1 Million |
Debt repayment | -967.7 Million | -451.1 Million | -94.9 Million | -2.57 Billion | -174.6 Million | -485.2 Million |
Dividends payments | -157.3 Million | -157.3 Million | -1.81 Billion | -1.51 Billion | -141.3 Million | -141.3 Million |
Common Stock Repurchased | -500 Thousand | - | -4 Million | -3.5 Million | -400 Thousand | -100 Thousand |
Common Stock Issuance | 3 Million | 6.9 Million | 35.4 Million | 51.5 Million | 8.4 Million | 14.3 Million |
Other Financing Activities | 3 Million | 383.2 Million | 35.4 Million | 5.14 Billion | 1.25 Billion | 970.4 Million |
Accounts receivables | 47.1 Million | -497.2 Million | -42.9 Million | -1.26 Billion | 258.39 Million | -229.9 Million |
Accounts payables | -43.4 Million | -42.5 Million | 584.9 Million | 350.7 Million | -99.29 Million | 102.6 Million |
Inventory | 176.9 Million | -59.4 Million | -203.8 Million | -350.7 Million | 99.3 Million | 44.3 Million |
Other working capital | -119.7 Million | -321.3 Million | 81.6 Million | -68.2 Million | -852.6 Million | -32.1 Million |
Cash at beginning of period | 5.87 Billion | 6.19 Billion | 7.18 Billion | 4.69 Billion | 5.9 Billion | 5.14 Billion |
Cash at end of period | 6.84 Billion | 5.87 Billion | 6.19 Billion | 2.42 Billion | 1.18 Billion | 5.9 Billion |
Capital Expenditure | -378.1 Million | -512.79 Million | -351.8 Million | -1.26 Billion | -363.4 Million | -335.7 Million |
Effect of forex changes on cash | 64.1 Million | -20 Million | -50.1 Million | 69.6 Million | 85.9 Million | -54.3 Million |
Net cash flow / Change in cash | 977.7 Million | -323 Million | -987.2 Million | -2.26 Billion | -4.71 Billion | 760.4 Million |
Free Cash Flow | 908.1 Million | -72.79 Million | 1.11 Billion | 2.92 Billion | 823.3 Million | 1 Billion |
300380
TOE
FTNT
AUROPHARMA
GSTC
NCL